Skip to main content
U.S. flag

An official website of the United States government

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

Search help
7 results
  1. Key Question 3: Efficacy and Harms of Prescription Drug Treatment Versus Placebo for Cognition, Function, and Quality ... 
    https://www.ncbi.nlm.nih.gov/books/NBK556554
    ... Cognition SIB Function ADCS-ADL-SIV Global Change ADCS-CGIC Harms Serious adverse events Withdrawals due to adverse ... ADAS-Cog MMSE Function ADCS-ADL Global Change ADCS-CGIC Harms Serious adverse events Withdrawals due to adverse ...
  2. Key Question 4: Efficacy and Harms of Supplements Versus Placebo for Cognition, Function, and Quality of Life - ... 
    https://www.ncbi.nlm.nih.gov/books/NBK556544
    ... Quality of Life Scale Clinical Impression of Change ADCS-CGIC Harms SAEs McCarney 2008 223 RCT England High ... Relative’s Rating Instrument Clinical Impression of Change ADCS-CGIC Harms Withdrawal due to AEs SAEs Mazza 2006 ...
  3. Cholinesterase inhibitors and memantine for dementia - Dementia - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK536484
    ... response between memantine and placebo, as assessed by ADCS-CGIC. 11.3.4.1.4. Activities of daily ... function between memantine and placebo, as assessed by ADCS-CGIC. Low-quality evidence from 1 RCT could not ...
  4. Results - Nonpharmacologic Interventions for Agitation and Aggression in Dementia - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK356168
    ... Disease Cooperative Study-Clinical Global Impression of Change (ADCS-CGIC); continuous variables based upon scores on the ABID ...
  5. Meta-analysis & network meta-analysis results - Dementia - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK536506
    ... rofecoxib ADCS-ADL, IDDD & BADLS (12 months: SMD) ADCS-ADL, IDDD & BADLS (12 months: SMD) – sensitivity analysis excluding rofecoxib CIBIC+ (6 months) CIBIC+ & CGIC (6 months: SMD) CIBIC+ (12 months) CIBIC+ (12 ...
  6. Key Question 5: Comparative Effectiveness and Harms of Prescription Drug Treatment Versus Other Active Treatments for ... 
    https://www.ncbi.nlm.nih.gov/books/NBK556560
    ... Cog=Alzheimer’s Disease Assessment Scale-Cognitive subscale; ADCS-ADL=Alzheimer’s ... GDS=Global Deterioration Scale; IADL=Instrumental Activities of ...
  7. Managing non-cognitive symptoms - Dementia - NCBI Bookshelf 
    https://www.ncbi.nlm.nih.gov/books/NBK536509
    ... estimated using data obtained from the EQ-5D questionnaire. The authors performed non-parametric bootstrapping to generate ... sleep behaviour disorder (measured using the Stavanger Sleep Questionnaire) in people with sleep problems taking memantine versus ...